The go-ahead for Novartis’ oral treatment marks a new option for patients with spontaneous urticaria who remain symptomatic despite antihistamine therapy.
Here’s what gua sha is, when it may be helpful and what to keep in mind before adding it to your self-care routine.
Swiss pharmaceutical giant Novartis ($NVS) has secured the approval of the U.S. health regulator for its new pill Rhapsido.
Sensitive skin is good at complicating things. The skin appears to be serene one minute, and the next, it's on fire, itches, or spots break out on it for no apparent reason. Individuals accuse the new ...
Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA® ...
Treat your eczema by partnering with a board-certified dermatologist. You might need to change your treatment plan, depending ...
Remibrutinib also in clinical development for chronic inducible urticaria, food allergy, and hidradenitis suppurativa, expanding Novartis Immunology portfolio ...
Rhapsido helps to inhibit release of histamine and proinflammatory mediators by targeting BTK, offering unique approach to CSU treatment 1 Well-controlled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback